FCRL2 and hematocrit: In an earlier study, FCRL2 and FCRL4 gene expression levels showed no correlation with the levels of TPOAbs and TgAbs from GD and HT patients [11]; however—in another study—FCRL3 expression positively correlated with TPOAb levels in HT [18].